DECR1 directly activates HSL to promote lipolysis in cervical cancer cells

Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Mar;1867(3):159090. doi: 10.1016/j.bbalip.2021.159090. Epub 2021 Dec 10.

Abstract

Fatty acids have a high turnover rate in cancer cells to supply energy for tumor growth and proliferation. Lipolysis is particularly important for the regulation of fatty acid homeostasis and in the maintenance of cancer cells. In the current study, we explored how 2,4-Dienoyl-CoA reductase (DECR1), a short-chain dehydrogenase/reductase associated with mitochondrial and cytoplasmic compartments, promotes cancer cell growth. We report that DECR1 overexpression significantly reduced the triglyceride (TAG) content in HeLa cells; conversely, DECR1 silencing increased intracellular TAG content. Subsequently, our experiments demonstrate that DECR1 promotes lipolysis via effects on hormone sensitive lipase (HSL). The direct interaction of DECR1 with HSL increases HSL phosphorylation and activity, facilitating the translocation of HSL to lipid droplets. The ensuing enhancement of lipolysis thus increases the release of free fatty acids. Downstream effects include the promotion of cervical cancer cell migration and growth, associated with the enhanced levels of p62 protein. In summary, high levels of DECR1 serves to enhance lipolysis and the release of fatty acid energy stores to support cervical cancer cell growth.

Keywords: Fatty acids; Hormone sensitive lipase (HSL); Lipolysis; Triglyceride; p62.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Lipolysis*